Molecular landscape of <scp><i>TP53</i></scp> mutations in breast cancer and their utility for predicting the response to <scp>HER</scp>‐targeted therapy in <scp>HER2</scp> amplification‐positive and <scp>HER2</scp> mutation‐positive amplification‐negative patients
Binliang Liu(Central South University), Yixin Zeng(Sun Yat-sen University), Fei Ma(Chinese Academy of Medical Sciences & Peking Union Medical College), Jingtong Zhai(Chinese Academy of Medical Sciences & Peking Union Medical College), Zongbi Yi(Wuhan University), Haili Qian(Chinese Academy of Medical Sciences & Peking Union Medical College), Chunxiao Li(Qingdao University), Binghe Xu(Chinese Academy of Medical Sciences & Peking Union Medical College), Quchang Ouyang(Hunan Cancer Hospital), Dan Lv(Tianjin Third Central Hospital), Xiuwen Guan(Chinese Academy of Medical Sciences & Peking Union Medical College), Yanfang Guan(Xi'an Jiaotong University), Lixi Li(Chinese Academy of Medical Sciences & Peking Union Medical College)
Cited by 27
Related Papers
Targeted therapeutic options and future perspectives for HER2-positive breast cancer
|Signal Transduction and Targeted Therapy|2019|406
Biological effects of radiation on cancer cells
|Military Medical Research|2018|238
Autophagy Enhancer Carbamazepine Alleviates Memory Deficits and Cerebral Amyloid-&beta; Pathology in a Mouse Model of Alzheimer&apos;s Disease
|Current Alzheimer Research|2013|148
Long-Term Treatment with Lithium Alleviates Memory Deficits and Reduces Amyloid-β Production in an Aged Alzheimer's Disease Transgenic Mouse Model
|Journal of Alzheimer s Disease|2011|114